Nanocoatings, degradable metals and surface fonctionnalisation: Towards high-performance cardiovascular biomaterials

D. Mantovani
{"title":"Nanocoatings, degradable metals and surface fonctionnalisation: Towards high-performance cardiovascular biomaterials","authors":"D. Mantovani","doi":"10.1109/ICICI-BME.2011.6108585","DOIUrl":null,"url":null,"abstract":"The need for highly performing vascular biomaterials is rapidly increasing with the ageing of population. Vascular diseases are the primary cause of death in the world and at least 1 million patients undergo to surgical operation for prosthesis implantation each year worldwide to face cardiovascular occlusive diseases, aneurysms and acute renal failures. As the major problem still resides in an interfacial mismatch between the synthetic inert graft and the natural living tissue surrounding it, the common approaches consist of modulating the tissue/biomaterial interface by modifying the synthetic graft surface properties, in an attempt to improve their long-term biocompatibility and hemocompatibility. Thus, several coating techniques, including plasma-based treatments, were investigated during the last 20 years to improve clinical performances of cardiovascular devices, including stents and vascular prostheses. Strong binding of selected bio-molecules, including protein-repellent ones, surface patterning, and a number of other strategies has already been investigated in order to obtain biological-like surfaces based on the hypothesis that the human body would positively interact with these biological coated materials. Nevertheless, such coatings did not completely successes clinically as it turned out that the bioactive materials could not play their biological role as well as expected and eventually led to the development of negative interactions and finally to clinical complications. Today, nanotechnology and surface modifications provides a new insight to the current problem of biomaterial failures, and even allows us to envisage strategies for the organ shortage. Advanced tools and new paths towards the development of functional solutions for cardiovascular clinical applications are now available. Within this general framework, this talk will focus on highly-adherent and strongly-cohesive (after deployment) fluorocarbon nano-coatings for intravascular stents, bio-mimicking coatings for vascular prostheses, and degradable metals for temporary devices. The intrinsic goal is to present an extremely personal look at how materials and surface modifications have progressed, from the glory days of their introduction, to the promising future that nanotechnology may or may not hold for improving the quality of the life of millions worldwide.","PeriodicalId":395673,"journal":{"name":"2011 2nd International Conference on Instrumentation, Communications, Information Technology, and Biomedical Engineering","volume":"61 1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2011-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2011 2nd International Conference on Instrumentation, Communications, Information Technology, and Biomedical Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ICICI-BME.2011.6108585","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The need for highly performing vascular biomaterials is rapidly increasing with the ageing of population. Vascular diseases are the primary cause of death in the world and at least 1 million patients undergo to surgical operation for prosthesis implantation each year worldwide to face cardiovascular occlusive diseases, aneurysms and acute renal failures. As the major problem still resides in an interfacial mismatch between the synthetic inert graft and the natural living tissue surrounding it, the common approaches consist of modulating the tissue/biomaterial interface by modifying the synthetic graft surface properties, in an attempt to improve their long-term biocompatibility and hemocompatibility. Thus, several coating techniques, including plasma-based treatments, were investigated during the last 20 years to improve clinical performances of cardiovascular devices, including stents and vascular prostheses. Strong binding of selected bio-molecules, including protein-repellent ones, surface patterning, and a number of other strategies has already been investigated in order to obtain biological-like surfaces based on the hypothesis that the human body would positively interact with these biological coated materials. Nevertheless, such coatings did not completely successes clinically as it turned out that the bioactive materials could not play their biological role as well as expected and eventually led to the development of negative interactions and finally to clinical complications. Today, nanotechnology and surface modifications provides a new insight to the current problem of biomaterial failures, and even allows us to envisage strategies for the organ shortage. Advanced tools and new paths towards the development of functional solutions for cardiovascular clinical applications are now available. Within this general framework, this talk will focus on highly-adherent and strongly-cohesive (after deployment) fluorocarbon nano-coatings for intravascular stents, bio-mimicking coatings for vascular prostheses, and degradable metals for temporary devices. The intrinsic goal is to present an extremely personal look at how materials and surface modifications have progressed, from the glory days of their introduction, to the promising future that nanotechnology may or may not hold for improving the quality of the life of millions worldwide.
纳米涂层、可降解金属和表面功能化:迈向高性能心血管生物材料
随着人口的老龄化,对高性能血管生物材料的需求正在迅速增加。血管疾病是世界上导致死亡的主要原因,全世界每年至少有100万患者因心血管闭塞性疾病、动脉瘤和急性肾功能衰竭而接受外科手术。由于主要问题仍然是合成惰性移植物与其周围天然活组织之间的界面不匹配,常用的方法包括通过改变合成移植物的表面特性来调节组织/生物材料界面,以试图提高其长期生物相容性和血液相容性。因此,在过去的20年中,研究了几种涂层技术,包括基于等离子体的治疗,以改善心血管装置的临床性能,包括支架和血管假体。基于人体会与这些生物涂层材料积极相互作用的假设,为了获得类生物表面,已经研究了选定生物分子的强结合,包括蛋白质排斥分子、表面图案和许多其他策略。然而,这种涂层在临床上并没有完全成功,因为生物活性物质并没有像预期的那样发挥其生物学作用,最终导致负相互作用的发展,最终导致临床并发症。今天,纳米技术和表面修饰为当前生物材料失效的问题提供了新的见解,甚至使我们能够设想器官短缺的策略。先进的工具和开发心血管临床应用功能解决方案的新途径现在是可用的。在这个总体框架内,本次演讲将重点关注用于血管内支架的高粘附性和强粘性(部署后)氟碳纳米涂层,用于血管假体的生物模拟涂层,以及用于临时设备的可降解金属。其内在目标是以个人视角展示材料和表面修饰是如何发展的,从它们引入的辉煌岁月,到纳米技术可能或可能无法改善全球数百万人生活质量的充满希望的未来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信